As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Featured article by Jules Angst and colleagues: Bipolar disorders in ICD-11: current status and strengths
Compared to ICD-10 and DSM-5, the current ICD-11 definition of hypomanic episodes represents important progress. Hypomanic episodes will be diagnosed twice as frequently as manic episodes.
We are delighted to announce International Journal of Bipolar Disorders' first Impact Factor is 3.55!
IJBD is also indexed by PubMed Central and the Directory of Open Access Journals (DOAJ). All articles will be indexed in both services shortly after publication. Submit your article now!
Announcing the launch of In Review
International Journal of Bipolar Disorders, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Thematic Series: Controversies in Bipolar Disorders
Aims and scope
International Journal of Bipolar Disorders is affiliated with IGSLI (International Group for The Study of Lithium Treated Patients)
Annual Journal Metrics
45 days to first decision for reviewed manuscripts only
44 days to first decision for all manuscripts
80 days from submission to acceptance
52 days from acceptance to publication
185 Altmetric Mentions
- ISSN: 2194-7511 (electronic)